Fluorescent Imaging of β-Amyloid Using BODIPY Based Near-Infrared Off–On Fluorescent Probe
Authors:
- Wenming RenWRWenming Ren
- Chengyuan PengCPChengyuan Peng
- Ruimin HuangRHRuimin Huang
- Haiyan ZhangHZHaiyan Zhang
- Youhong HuYHYouhong Hu
- 6 September 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 29 (10) , 3459-3466
Abstract
Fluorescent imaging of β-amyloid (Aβ) is one of the most promising methods for Alzheimer’s disease diagnosis. Several fluorescent probes have been reported to detect Aβ both in vitro and in vivo. However, highly sensitive and highly selective probes with low background signals are still greatly needed. Herein, we rationally designed and synthesized a PIET quenched near-infrared probe QAD-1 to detect Aβ. This probe contains BODIPY as fluorophore and tetrahydroquinoxaline as the quenching group. QAD-1 exhibited significant fluorescent switch-on after binding to soluble and insoluble Aβ species, and the probe had the benefit of low background signal to stain Aβ plaques without the need of wash-out procedures in vitro, which was specially found by the fluorescence off–on probe. QAD-1 could identify the overproduced Aβ in transgenic (APPSWE/PSEN 1dE9) AD mice as early as 6 months old in vivo, which indicated that QAD-1 may be a potential probe for monitoring Aβ species at an early stage of AD.Keywords
Funding Information
- China Postdoctoral Science Foundation (2017M611638)
- National Natural Science Foundation of China (81522045, 81771890)
- Chinese Academy of Sciences (CASIMM0120163010, XDA12040207)
This publication has 37 references indexed in Scilit:
- 2017 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2017
- Advances in development of fluorescent probes for detecting amyloid-β aggregatesActa Pharmacologica Sinica, 2016
- Amyloid plaques are still main target for Alzheimer’s drugsBMJ, 2016
- Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- Imaging of β-amyloid plaques by near infrared fluorescent tracers: a new frontier for chemical neuroscienceChemical Society Reviews, 2015
- Florbetaben for PET Imaging of Beta-Amyloid Plaques in the BrainNeurology and Therapy, 2014
- Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?Current Opinion in Psychiatry, 2014
- Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physiciansAlzheimer's Research & Therapy, 2013
- Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environmentEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeThe Lancet Neurology, 2010